Anti-hyperalgesic effects of the novel metabotropic glutamate receptor 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine, in rat models of inflammatory pain

被引：0
|
作者：
Bowes, M
Panesar, M
Gentry, C
Urban, L
Gasparini, F
Kuhn, R
Walker, K
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Inst Med Sci, London WC1E 6BN, England
来源：
BRITISH JOURNAL OF PHARMACOLOGY | 1999年 / 126卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
250P
引用
收藏
页码：U130 / U130
页数：1
相关论文
共 50 条
  • [1] Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents
    Spooren, WPJM
    Vassout, A
    Neijt, HC
    Kuhn, R
    Gasparini, F
    Roux, S
    Porsolt, RD
    Gentsch, C
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2000, 295 (03): : 1267 - 1275
  • [2] The novel, selective mGlu5 receptor antagonist, 2-methyl-6-(phenylethynyl)-pyridine, reverses mechanical hyperalgesia in rat models of inflammatory pain
    Walker, K
    Bowes, M
    Gasparini, F
    Kuhn, R
    Urban, L
    NEUROPHARMACOLOGY, 1999, 38 (10) : A46 - A46
  • [3] The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats
    Schulz, B
    Fendt, M
    Gasparini, F
    Lingenhöhl, K
    Kuhn, R
    Koch, M
    NEUROPHARMACOLOGY, 2001, 41 (01) : 1 - 7
  • [4] Attenuation of behavioral effects of cocaine by the metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)-pyridine in squirrel monkeys: Comparison with dizocilpine
    Lee, B
    Platt, DM
    Rowlett, JK
    Adewale, AS
    Spealman, RD
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 312 (03): : 1232 - 1240
  • [5] Effect of metabotropic glutamate receptor subtype 5 antagonist, 2-methyl-6-(phenylethynyl)-pyridine on mechanosensory afferents innervating rat hind paw following inflammation
    Su, X
    Urban, MO
    NEUROSCIENCE LETTERS, 2005, 390 (03) : 123 - 128
  • [6] 2-methyl-6-(phenylethynyl)-pyridine (MPEP): A novel potent, subtype-selective and systemically active antagonist at metabotropic glutamate receptor subtype
    Gasparini, F
    Lingenhoehl, K
    Flor, PJ
    Munier, N
    Heinrich, M
    Pagano, A
    Vranesic, I
    Biollaz, M
    Heckendorn, R
    Allgeier, H
    Varney, M
    Johnson, E
    Hess, SD
    Velicelebi, G
    Kuhn, R
    Urban, L
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 126 : U130 - U130
  • [7] In vivo evidence that the metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) acts as an inhibitor of the norepinephrine transporter
    Heidbreder, C
    Bianchi, M
    Lacroix, L
    Crespi, F
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 138 : U104 - U104
  • [8] METABOTROPIC GLUTAMATE RECEPTOR 5 ANTAGONIST 2-METHYL-6-(PHENYLETHYNYL)PYRIDINE PRODUCES ANTIDEPRESSANT EFFECTS IN RATS: ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR
    Liu, C. Y.
    Jiang, X. X.
    Zhu, Y. H.
    Wei, D. N.
    NEUROSCIENCE, 2012, 223 : 219 - 224
  • [9] The Metabotropic Glutamate Receptor Subtype 5 Antagonist Fenobam Is Analgesic and Has Improved in Vivo Selectivity Compared with the Prototypical Antagonist 2-Methyl-6-(phenylethynyl)-pyridine
    Montana, Michael C.
    Cavallone, Laura F.
    Stubbert, Kristi K.
    Stefanescu, Andrei D.
    Kharasch, Evan D.
    Gereau, Robert W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03): : 834 - 843
  • [10] Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats
    Klodzinska, A
    Tatarcynska, E
    Chojnacka-Wójcik, E
    Pilc, A
    POLISH JOURNAL OF PHARMACOLOGY, 2000, 52 (06): : 463 - 466
12345